Viewing Study NCT04851834

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-03-17 @ 3:26 AM
Study NCT ID: NCT04851834
Status: TERMINATED
Last Update Posted: 2022-12-20
First Post: 2021-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
Sponsor: Xennials Therapeutics Australia Pty Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Platinum-Resistant Ovarian Cancer View
None Platinum-Resistant Urothelial Carcinoma View
None High-grade Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypomethylating Agent View
None Nucleoside Analog View
None DNA Demethylation View
None Solid Tumors View
None Ovarian Neoplasms View
None Urinary Bladder Neoplasms View
None Platinum-resistant View
None Carboplatin View
None Cisplatin View
None Glioma View
None IDH1 View
None Temozolomide View